JB
LEGN icon

Julian Baker’s Legend Biotech LEGN Stock Holding History

Julian Baker’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-856,658
Closed -$47.1M – 121
2022
Q2 		$47.1M Sell
856,658
-1,152,341
-57% -$48.7M 0.27% 25
2022
Q1 		$73M Sell
2,008,999
-480,004
-19% -$19M 0.42% 21
2021
Q4 		$116M Buy
2,489,003
+125,000
+5% +$6.34M 0.56% 16
2021
Q3 		$120M Buy
2,364,003
+699,469
+42% +$29.1M 0.52% 18
2021
Q2 		$68.3M Buy
1,664,534
+1,548,908
+1,340% +$52.6M 0.3% 30
2021
Q1 		$3.35M Hold
115,626
– – 0.01% 105
2020
Q4 		$3.26M Sell
115,626
-12,574
-10% -$362K 0.01% 102
2020
Q3 		$3.96M Sell
128,200
-6,800
-5% -$229K 0.02% 86
2020
Q2 		$5.75M Buy
+135,000
New +$5.27M 0.03% 77

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Julian Baker's LEGN Position: Q3 2022 in Review

Julian Baker sold out of Legend Biotech (LEGN) in Q3 2022, closing a stake of 856,658 shares — an estimated $47.1M sold.

Julian Baker first reported a position in LEGN in Q2 2020 and held it in 9 quarters. The position peaked at $120M in Q3 2021. 159 funds tracked by Wall St. Rank hold LEGN as of Q3 2022.

  • Julian Baker reported no remaining Legend Biotech position as of Q3 2022 after selling out during the quarter.
  • Julian Baker sold 856,658 Legend Biotech shares in Q3 2022, an estimated $47.1M.
  • Julian Baker first reported a position in Legend Biotech in Q2 2020 and held it in 9 quarters.
  • Julian Baker's Legend Biotech position peaked at $120M in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2022.

Based on Baker Bros. Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.